The Oxford Parkinson's Disease Centre (OPDC) is a unique multidisciplinary research centre at the University of Oxford supported by Parkinson’s UK with funds from The Monument Trust, one of the Sainsbury Family Charitable Trusts.
Established in February 2010, the Oxford Parkinson’s Disease Centre (OPDC) brings together internationally-renowned scientists who work on the genetics of Parkinson’s, the generation of cell and animal models, and the wiring of brain circuits which control movement, with clinical experts in the diagnosis and treatment of Parkinson’s.
Our programme targets the molecular pathways to Parkinson’s in order to:
Arora S, Baig F, Lo C, Barber TR, Lawton MA, Zhan A, Rolinski M, Ruffmann C, Klein JC, Rumbold J, Louvel A, Zaiwalla Z, Lennox G, Quinnell T, Dennis G, Wade-Martins R, Ben-Shlomo Y, Little MA, Hu MT. (2018) Smartphone motor testing to distinguish idiopathic REM sleep behavior disorder, controls, and PD. Neurology. PMID:30232246
Barber TR, Griffanti L, Muhammed K, Drew DS, Bradley KM, McGowan DR, Crabbe M, Lo C, Mackay CE, Husain M, Hu MT, Klein JC; Oxford Parkinson's Disease Centre. (2018) Apathy in rapid eye movement sleep behaviour disorder is associated with serotonin depletion in the dorsal raphe nucleus. Brain. PMID:30212839
The Medical Research Council Brain Network Dynamics Unit at the University of Oxford recently welcomed Lord James O’Shaughnessy, Parliamentary Under-Secretary of State for Health, for a site visit organised as part of The Royal Society’s Pairing Scheme that OPDC theme 3 co-lead Professor Pete Magill is taking part in. The visit began with Unit Group Leaders Peter Brown, Peter Magill and Tim Denison highlighting why, how and where the Unit ...
Parkinson’s is the second most common neurodegenerative disease, the hallmarks of which include tremor, stiffness, and slowness of movement. Existing tests for the assessment of Parkinson's require in-clinic examination. This can sometimes cause a delay in diagnosis. It is believed that there are changes in the brain 5 to 10 years before the symptoms of Parkinson's become evident. To try and facilitate early diagnosis of Parkinson's, we at the ...
On September 10th, 2018 over 200 members of Discovery cohort came to the Jury’s Inn, Oxford to hear about our latest research and share their views. We would like to thank all of the cohort members who came to the event from our centres across the country, and joined in the lively discussion session. Researchers from across OPDC’s themes shared their work. These included talks on our work to develop a new test for Parkinson’s, how we are using ...
Click here to sign up to the OPDC News Mailing list
Using transcriptomics to understand neurodegenerative disorders MRC Post-doctoral Fellow UCL Institute of Neurology As an MBPhD graduate (Cambridge University & University College London) and Academic Clinical Fellow in Neurology (London Deanery), I have been lucky enough to receive training in basic research as well as clinical medicine. I have thoroughly enjoyed both and am committed to pursuing a joint clinical and research career in ...
Challenges and Opportunities of Translational Neurogenomics Dr. Scholz is a Neurologist and Neurogeneticist specialized in movement disorders. She received her medical degree from the Medical University Innsbruck, Austria. Following graduation, she was a post-doctoral fellow at the Laboratory of Neurogenetics (NIA) under the supervision of Drs. Andrew Singleton and John Hardy. She obtained a Ph.D. in Neurogenomics from the University ...
© 2018 Oxford Parkinson's Disease Centre, Department of Physiology, Anatomy and Genetics, Le Gros Clark Building, South Parks Road, Oxford, OX1 3QX
Tel: 01865 282358 | Enquiries: opdc.administrator@dpag.ox.ac.uk
Driven by 
Newt, Powered by 
Pinfox
Home | Site Map | Contact | Freedom of Information | Privacy Policy | Copyright | Accessibility | Medical Sciences Division | Oxford University
